Generation Bio Co. Common Stock(GBIO)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$5.61
52-Week Range
$3.00 – $6.95
YTD
+3.03%
IV Rank (30D)
0
Straddle Price
$4.65
P/C Vol Ratio
0.00
Market Cap
$0.0B
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.0B

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selec…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +3.42% 6
Feb -3.00% 6
Mar +13.17% 5
Apr -0.81% 5
May -9.44% 5
Jun +2.67% 6
Jul +4.70% 6
Aug +10.90% 6
Sep -3.67% 6
Oct -21.96% 6
Nov +8.97% 6
Dec -17.77% 6
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $5.61
SMA 50: $5.49
SMA 200: $5.08
Current: $5.34
EMA 12: $5.60
EMA 26: $5.58
MACD: 0.0174 | Signal: -0.0198
BULLISH
ADX (14): 15.80
RANGE
+DI: 13.45
−DI: 21.45
Momentum Oscillators
RSI (14): 39.71
NEUTRAL
Stoch %K: 52.43
Stoch %D: 70.63
Williams %R: -100.00
Volume & Volatility
BB Upper: $5.79
BB Lower: $5.43
OVERSOLD
OBV: 11,283,936
Vol SMA 20: 133,309
Vol ROC: 756.76%
ATR: $0.19
True Range: $0.40
HV 20: 35.3%
HV 30: 32.7%
HV 60: 34.6%

Data Summary
Data Points: 500
Last Updated: 2026-06-13T13:41:21.130000
Date Range: 2024-02-09T00:00:00 – 2026-02-06T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
6 of 6 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-07 After-Close 70.95% 8.11% 0.11x Within
2024-11-06 Pre-Market 84.47% 9.59% 0.11x Within
2025-03-13 Pre-Market 757.01% 2.67% 0.00x Within
2025-05-07 Pre-Market 523.35% 4.74% 0.01x Within
2025-08-12 Pre-Market 120.05% 2.72% 0.02x Within
2025-11-05 Pre-Market 90.48% 1.14% 0.01x Within
Options Activity
IV Rank (30D)
0
IV Rank (7D)
0
Avg IV
0.0%
Straddle (30D)
$4.65
Straddle (7D)
$4.65
P/C Volume
0.00
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.32
Correlation (SPY)
13.4%
0.02
Ann. Volatility
108.6%
SPY Volatility
11.0%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

6 filers701,403 shares$4.04M value
# Filer Shares Value % of Total % of Float Period
1 Opaleye Management Inc. 310,000 $1.76M 43.63% 2025-12-31
2 VANGUARD GROUP INC Custodian 229,833 $1.31M 32.34% 2025-12-31
3 MORGAN STANLEY Custodian 161,378 $916.63K 22.71% 2025-12-31
4 Accent Capital Management, LLC 61 $53.26K 1.32% 2026-03-31
5 Essential Partners LLC 130 $42 <0.01% 2025-06-30
6 HUNTINGTON NATIONAL BANK Custodian 1 $0 0.00% 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2026-02-09
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-02-09 Ronald Harold Wilfred Cooper Director U −950 EDGAR
2026-02-09 Anthony G. Quinn Director U −37,211 EDGAR
2026-02-09 Yalonda Howze INTERIM CEO AND PRESIDENT U −3,759 EDGAR
2026-02-09 Gustav Christensen Director U −13,142 EDGAR
2026-02-09 Catherine Stehman-Breen Director U −4,752 EDGAR
2026-02-09 GEOFF MCDONOUGH Director U −188,638 EDGAR
2026-02-09 Kevin John Conway CHIEF FINANCIAL OFFICER U −2,072 EDGAR
2026-02-09 Dannielle Appelhans Director U −1,999 EDGAR
2026-02-09 Atlas Venture Associates X, LLC 10%+ Owner U −4,967,676 EDGAR
2026-02-09 JEFFREY M JONAS Director Disp (D) −24,366 opt EDGAR
2026-02-09 Donald William Nicholson Director U −21,357 EDGAR
2026-02-09 Jason P Rhodes Director U −827,946 EDGAR
2026-02-09 Charles A Jr Rowland Director U −53,475 EDGAR
2026-02-04 GEOFF MCDONOUGH Director Mixed +1,032 $5.64 -$3.1K EDGAR
2026-02-04 Yalonda Howze INTERIM CEO & PRESIDENT Mixed +1,178 $5.64 -$2.8K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
17 insiders · @ $5.34
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 ATLAS VENTURE ASSOCIATES X, L.P. 10%+ Owner 9,111,939 $48.66M -$14.46M 2 2021-04-14
2 Atlas Venture Fund X, L.P. 10%+ Owner 8,278,876 $44.21M $0 4 2021-09-21
3 Atlas Venture Opportunity Fund I, L.P. 10%+ Owner 7,111,939 $37.98M -$8.24M 1 2021-09-29
4 Thomas G. Jr. Roberts 10%+ Owner 3,437,638 $18.36M $76.00M 1 2020-06-17
5 William Seybold 10%+ Owner 3,437,638 $18.36M $30.40M 1 2020-06-17
6 Artal Group S.A. 10%+ Owner 2,814,191 $15.03M $136.80M 1 2020-06-18
7 Eli Casdin 10%+ Owner 1,611,215 $8.60M $24.70M 1 2020-06-18
8 Wellington Biomedical Innovation Master Investors (Cayman) I L.P. 10%+ Owner 1,012,546 $5.41M $20.90M 1 2020-06-18
9 DEERFIELD PARTNERS, L.P. 10%+ Owner 961,215 $5.13M $17.10M 1 2020-06-16
10 Mark D. Angelino CHIEF OPERATING OFFICER 516,583 $2.76M -$432.7K 3 2021-01-20
11 Douglas Kerr CHIEF MEDICAL OFFICER 385,628 $2.06M -$1.55M 16 2024-01-31
12 Matthew Stanton CHIEF SCIENTIFIC OFFICER 247,319 $1.32M -$2.90M 32 2024-10-17
13 Matthew Norkunas CHIEF FINANCIAL OFFICER 56,659 $302.6K $0 16 2024-10-17
14 Tracy Zimmermann CHIEF DEVELOPMENT OFFICER 49,164 $262.5K -$559.1K 17 2024-01-31
15 Phillip Samayoa CHIEF SCIENTIFIC OFFICER 14,172 $75.7K -$30.0K 20 2025-10-17
16 Antoinette Paone CHIEF OPERATING OFFICER 3,705 $19.8K -$128.7K 27 2025-10-17
17 Atlas Venture Associates Opportunity I, LLC 10%+ Owner 616 $3.3K -$21.75M 2 2021-06-28
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.